Trending Now
DON'T MISS
High doses of ketamine can temporarily switch off the brain, say...
Researchers have identified two brain phenomena that may explain some of the side-effects of ketamine. Their measurements of the brain waves of sheep sedated by...
Antihistamines and similar drugs could slow down Huntington’s disease
Controlling dopamine signalling by targeting the histamine receptor has been shown to be a promising strategy for preventing the progression of Huntington’s disease in...
TRAVEL GUIDE
Huntington Study Group Researchers Combat Huntington’s Disease
Dr. Francis Walker of Wake Forest Baptist Medical Center discusses Huntington's disease, HSG research, and NC nonprofit HD Reach
North Carolina has emerged as a...
Lighting the way: A new biomarker for Huntington’s disease
In Huntington’s disease, brain cells begin dying long before disease symptoms arise. Unfortunately, good tools for monitoring early brain changes – and testing whether...
PHONES & DEVICES
Vaccinex Provides Update of Potentially Pivotal SIGNAL Clinical Trial in Huntington’s...
Topline data anticipated in October 2020 as previously guided
ROCHESTER, N.Y., July 07, 2020 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody...
Ohio State Conducts First Gene Therapy Clinical Trial For Huntington’s Disease
COLUMBUS, Ohio – In a worldwide first, surgeons at The Ohio State University Wexner Medical Center have treated two patients with Huntington’s disease using a novel...
LATEST TRENDS
When Cytokinin, a Plant Hormone, Meets the Adenosine A2A Receptor: A...
Abstract Top
It is well known that cytokinins are a class of phytohormones that promote cell division in plant roots and shoots. However, their targets, biological...
Major Wellcome Trust award to UCL boosts Huntington’s disease research
UCL today announced that a team of researchers from UCL and the University of Cambridge led by Professor Sarah Tabrizi, Director of the Huntington’s...
TECH
FASHION
REVIEWS
Vaccinex Provides Update of Potentially Pivotal SIGNAL Clinical Trial in Huntington’s...
Topline data anticipated in October 2020 as previously guided
ROCHESTER, N.Y., July 07, 2020 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody...
ENTERTAIMENT
